Skip to main content

Find Clinical Trials

Home
Conditions
Neuroblastoma

Clinical trial condition

Neuroblastoma

Explore clinical trials studying Neuroblastoma. Study availability and eligibility vary by location and protocol.

354 public trials 70 recruiting studies

Refine in advanced search Browse all conditions

Neuroblastoma trial results

Recruiting

68Ga-DOTATATE Neuroblastoma Imaging Pilot

NCT04559217

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations: McGill University Health Center - Children's hospital Montreal, Quebec, Canada

CHU Ste-Justine Montreal, Quebec, Canada

CIUSSS de l'Estrie-CHUS Hospital Sherbrooke, Quebec, Canada

View Trial Details

Recruiting

Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE)

NCT07172958

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Ewing Sarcoma, Female Urogenital Diseases, +32 more
Locations: Children's National Hospital Washington D.C., District of Columbia, United States

Childrens National Hospital Washington D.C., District of Columbia, United States

View Trial Details

Recruiting

B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)

NCT04897321

Conditions: Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, Adrenal Gland Diseases, +65 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Recruiting

Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid Tumors

NCT07584499

Conditions: Atypical Teratoid/Rhabdoid Tumors, Carcinoma, Carcinoma, Squamous Cell, +53 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Recruiting

Autologous B7-H3 Chimeric Antigen Receptor T Cells in Relapsed/Refractory Solid Tumors

NCT06500819

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Bone Tissue, +12 more
Locations: Stanford University Palo Alto, California, United States

View Trial Details

Recruiting

Phase II Study of Proton Radiation Therapy for Neuroblastoma

NCT02112617

Conditions: Ganglioneuroblastoma, Neoplasms, Neoplasms by Histologic Type, +8 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Recruiting

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

NCT04851119

Conditions: Adenocarcinoma, Adnexal Diseases, Carcinoma, +90 more
Locations: Children's Hospital of Alabama Birmingham, Alabama, United States

Children's Hospital Los Angeles Los Angeles, California, United States

Children's Hospital of Orange County Orange, California, United States

Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States

View all 21 locations

View Trial Details

Recruiting

Pediatric Precision Laboratory Advanced Neuroblastoma Therapy

NCT02559778

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations: University of Alabama/Children's of Alabama Birmingham, Alabama, United States

Arkansas Children's Hospital Little Rock, Arkansas, United States

UCSF Benioff Children's Hospital Oakland Oakland, California, United States

Rady Children's Hospital San Diego, California, United States

View all 28 locations

View Trial Details

Recruiting

Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma

NCT06540963

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations: Arkansas Children's Hospital Little Rock, Arkansas, United States

Connecticut Children's Hospital Hartford, Connecticut, United States

Nicklaus Children's Hospital Miami, Florida, United States

Arnold Palmer Hospital for Children Orlando, Florida, United States

View Trial Details

Recruiting

Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies

NCT04308330

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Ewing Sarcoma, Female Urogenital Diseases, +34 more
Locations: New York Medical College Valhalla, New York, United States

View Trial Details